カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

光学イメージングの世界市場予測（～2027）：製品別、技術別、治療領域別、用途別、エンドユーザー別

■ 英語タイトル：Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) - Global Forecast to 2027

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD2818-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD2818-23
■ 発行日：2023年2月27日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：250
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[光学イメージングの世界市場予測（～2027）：製品別、技術別、治療領域別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社によると、世界の光学イメージング市場規模が2022年15億ドルから2027年29億ドルに達し、予測期間中に年平均13.5％で成長すると予測されています。本調査レポートでは、光学イメージングの世界市場を広く調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（イメージングシステム、カメラ、ソフトウェア、レンズ、その他）分析、技術別（OCT、NIR、HIS、PAT）分析、用途別（病理イメージング、術中イメージング）分析、エンドユーザー別（病院＆クリニック、研究所、製薬＆バイオテクノロジー企業）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などについて以下の構成でまとめています。また、本書には、Carl Zeiss Meditec AG (Germany)、Abbott (US)、Topcon Corporation (Japan)、Canon Inc. (Japan)、PerkinElmer,Inc. (US)、Koninklijke Philips N.V. (Netherlands)、Heidelberg Engineering (US)、Leica Microsystems (Germany)、Headwall Photonics,Inc. (US)、Visionix (US)、Optical Imaging Ltd. (Israel)などの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の光学イメージング市場規模：製品別
- イメージングシステムの市場規模
- カメラの市場規模
- ソフトウェアの市場規模
- レンズの市場規模
- その他製品の市場規模
・世界の光学イメージング市場規模：技術別
- OCT技術の市場規模
- NIR技術の市場規模
- HIS技術の市場規模
- PAT技術の市場規模
・世界の光学イメージング市場規模：用途別
- 病理イメージングにおける市場規模
- 術中イメージンにおける市場規模
・世界の光学イメージング市場規模：エンドユーザー別
- 病院＆クリニックにおける市場規模
- 研究所における市場規模
- 製薬＆バイオテクノロジー企業における市場規模
・世界の光学イメージング市場規模：地域別
- 北米の光学イメージング市場規模
- ヨーロッパの光学イメージング市場規模
- アジア太平洋の光学イメージング市場規模
- 中南の光学イメージング市場規模
- 中東・アフリカの光学イメージング市場規模
・競争状況
・企業情報

“世界の光学イメージング市場は、2022年の15億米ドルから2027年には年平均成長率13.5％で拡大し、29億米ドルに達すると予測”
競争環境には、2019年1月から2023年1月の間に主要企業が採用した主要成長戦略の分析が含まれます。世界の光学イメージング市場のプレーヤーは、世界的な拠点を拡大し、市場シェアを拡大するために、契約、売却、拡張、買収など様々な戦略を採用しています。

“光学イメージング製品市場で最も急成長しているセグメントはソフトウェア”
イメージングプロセスで収集された体積データの効率的な可視化と定量的評価により、この市場で不可欠なサブセグメントとなっています。既存システムの継続的なアップグレードは、性能向上と正確な意思決定を可能にするハイテクソフトウェアソリューションにより可能です。また、大手企業は、エンドユーザー・サイトに設置済みのシステムに拡張機能を提供し、コスト効率を確保するための個別のソフトウェア・ソリューションも販売しています。したがって、この市場で最も急成長している分野です。

“光学イメージングアプリケーション市場で最も急成長している分野は手術”
医療プロセスにおける再現性と精度へのニーズの高まりと人件費の上昇が、手術市場の成長を後押ししています。さらに、さまざまな政府機関が投資や資金を通じて支援を拡大し、この市場の研究関連活動を促進しています。手術中のワークフローをサポートし、手術の意思決定を容易にすることが、術中分野における光学画像システムの採用率向上の主な理由です。

“光学イメージング市場で最大のシェアを占める光コヒーレンストモグラフィ分野”
光コヒーレンストモグラフィは、歯科、婦人科、泌尿器科など、多くの応用分野で導入され、需要が高まっていることから、技術分野で最大のシェアを占めています。新しいOCTシステムを発売する企業による開発イニシアチブの高まりも、市場成長に影響を与えています。光コヒーレンストモグラフィや光音響の技術力を搭載した光音響システムなど、技術的に優れたシステムの採用に対するエンドユーザーのニーズの高まりと、より安全で正確かつ精密なシステムに対する需要の高まりが、市場の成長を後押ししています。

“予測期間中、北米が光学イメージング市場を占める”
予測期間中、北米の光学イメージング市場が優勢であり、世界市場における北米の最大シェアは、癌症例の増加、神経学的イメージングの先端技術開発のための研究増加によるものです。主要な光学イメージングプレーヤの存在と老人人口の増加が市場成長に影響を与える要因となっています。さらに、前臨床試験や治療薬開発に従事する多くのバイオ製薬企業や研究所が北米の米国地域に存在することも、この地域の市場全体を押し上げています。

主要市場プレイヤー
光学イメージング市場の主なプレーヤーは、Carl Zeiss Meditec AG (Germany), Abbott (US), Topcon Corporation (Japan), Canon Inc. (Japan), PerkinElmer, Inc. (US), Koninklijke Philips N.V. (Netherlands), Heidelberg Engineering (US), Leica Microsystems (Germany), Headwall Photonics, Inc. (US), Visionix (US), Optical Imaging Ltd. (Israel), Optos (Scotland), Wasatch Photonics (Utah), ArcScan Inc.(US), DermaLumics (Spain), Cylite Pty Ltd. (Australia), MOPTIM (Guangdong), Michelson Diagnostics Ltd. (England), Thorlabs (US), Hamamatsu Photonics K.K. (Japan), iTheraMedical (Germany), Kibero (Germany), Seno Medical (US), Aspectus Imaging (Germany), and Agfa-Gevaert N.V (Belgium)です。

本レポートで参照した光学イメージング市場の主要参入企業の内訳（供給サイド別）は以下の通りです：
– 企業タイプ別 ティア1-42%、ティア2-31%、ティア3-27%
– 役職別 Cレベル-30%、ディレクターレベル-45%、その他-25%
– 地域別 北米-42%、欧州-28%、アジア太平洋地域-19%、南太平洋地域-11%

調査対象範囲
この調査レポートは、様々なセグメントにわたる光学イメージング市場を対象としています。製品別、用途別、エンドユーザー別、技術別、治療分野別、地域別など、さまざまなセグメントにわたって市場規模や成長性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品および事業内容に関する主な考察、最近の動向、主要な市場戦略も掲載しています。

レポート購入の主な利点
本レポートは、本市場における市場リーダー/新規参入者を支援し、光学イメージング市場とそのセグメントの最も近い近似値に関する情報を提供します。本レポートは、利害関係者が競争状況を理解し、事業をより良く位置づけるための洞察を得て、適切な市場参入戦略を計画するのに役立ちます。また、市場動向を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を得る上でも役立ちます。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION & SCOPE 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.3 MARKETS COVERED 35
FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION 35
1.3.1 YEARS CONSIDERED 36
1.4 CURRENCY 36
1.5 STAKEHOLDERS 36
1.6 LIMITATIONS 37
1.7 SUMMARY OF CHANGES 37
1.8 IMPACT OF RECESSION 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 2 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 3 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 45
FIGURE 9 COUNTRY-LEVEL ANALYSIS OF OPTICAL IMAGING MARKET 45
FIGURE 10 APPROACH 4: TOP-DOWN APPROACH 46
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF OPTICAL IMAGING MARKET 48
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 49
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 49
2.4 MARKET SHARE ASSUMPTIONS 50
2.5 ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 51
FIGURE 15 OPTICAL IMAGING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 16 OPTICAL IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 52
FIGURE 17 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION) 53
FIGURE 18 OPTICAL IMAGING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF OPTICAL IMAGING MARKET 54
4 PREMIUM INSIGHTS 55
4.1 OPTICAL IMAGING MARKET OVERVIEW 55
FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN OPTICAL IMAGING MARKET 55
4.2 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION AND COUNTRY 56
FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021 56
4.3 REGIONAL MIX: OPTICAL IMAGING MARKET 56
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 56
4.4 OPTICAL IMAGING MARKET: REGIONAL SNAPSHOT 57
FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 59
5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders 59
FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION 59
TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION) 60
5.2.1.2 Technological innovations 60
5.2.1.3 Growing application areas of optical imaging techniques 61
5.2.1.4 Growing need to minimize use of radiation technologies 61
TABLE 2 KEY MARKET DRIVERS 62
5.2.2 RESTRAINTS 62
5.2.2.1 Reimbursement challenges 62
5.2.2.2 Lack of skilled operators 62
TABLE 3 KEY MARKET RESTRAINTS 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Expansion and market penetration opportunities in emerging economies 63
TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060 64
5.2.3.2 Growing applications in pharmaceutical & biotechnology research 64
TABLE 5 KEY MARKET OPPORTUNITIES 65
5.2.4 CHALLENGES 65
5.2.4.1 Sustainability of small and medium-sized players 65
5.2.4.2 High cost of optical imaging procedures and extensive data requirements 65
TABLE 6 KEY MARKET CHALLENGES 66
5.3 PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 26 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 7 OPTICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.3.1 THREAT FROM NEW ENTRANTS 67
5.3.2 THREAT FROM SUBSTITUTES 68
5.3.3 BARGAINING POWER OF SUPPLIERS 68
5.3.4 BARGAINING POWER OF BUYERS 68
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.4 VALUE CHAIN ANALYSIS 69
FIGURE 27 OPTICAL IMAGING MARKET: VALUE CHAIN ANALYSIS 69
5.5 SUPPLY CHAIN ANALYSIS 69
FIGURE 28 OPTICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 71
5.6 REGULATORY ANALYSIS 71
TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS,
BY REGION 71
5.6.1 NORTH AMERICA 71
5.6.1.1 US 71
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 72
5.6.1.2 Canada 72
TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72
5.6.2 EUROPE 73
5.6.3 ASIA PACIFIC 73
5.6.3.1 Japan 73
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74
5.6.3.2 China 74
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
5.6.3.3 India 75
5.7 PATENT ANALYSIS 75
5.8 PRICING ANALYSIS 75
5.9 TRADE DATA 76
5.9.1 US 76
TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020 76
5.9.2 CHINA 76
5.9.3 UK 77
5.9.4 INDIA 77
6 OPTICAL IMAGING MARKET, BY PRODUCT 78
6.1 INTRODUCTION 79
TABLE 14 GLOBAL OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79
6.2 IMAGING SYSTEMS 79
TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.2.1 OPTICAL IMAGING SYSTEMS 81
6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth 81
TABLE 17 KEY OPTICAL IMAGING SYSTEMS 82
TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.2.2 SPECTRAL IMAGING SYSTEMS 83
6.2.2.1 Growing need for advanced imaging techniques to promote growth 83
TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.3 CAMERAS 84
6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS 84
TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.4 SOFTWARE 85
6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH 85
TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
6.5 LENSES 86
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES 86
TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.6 ILLUMINATION SYSTEMS 87
6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH 87
TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
6.7 OTHER PRODUCTS 88
TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89

7 OPTICAL IMAGING MARKET, BY TECHNIQUE 90
7.1 INTRODUCTION 91
TABLE 25 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 91
7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT) 91
7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH 91
TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.3 NEAR-INFRARED SPECTROSCOPY (NIRS) 93
7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH 93
TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.4 HYPERSPECTRAL IMAGING (HSI) 94
7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH 94
TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT) 95
7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH 95
TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
8 OPTICAL IMAGING MARKET, BY APPLICATION 97
8.1 INTRODUCTION 98
TABLE 30 OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
8.2 PATHOLOGICAL IMAGING 98
8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH 98
TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
8.3 INTRA-OPERATIVE IMAGING 99
8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET 99
TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA 101
9.1 INTRODUCTION 102
TABLE 33 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 102
9.2 OPHTHALMOLOGY 102
9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET 102
TABLE 34 OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 103
9.3 ONCOLOGY 104
9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH 104
TABLE 35 OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105
9.4 CARDIOLOGY 105
9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET 105
TABLE 36 OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.5 DERMATOLOGY 106
9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING 106
TABLE 37 OPTICAL IMAGING MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
9.6 NEUROLOGY 107
9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH 107
TABLE 38 OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
9.7 OTHER THERAPEUTIC AREAS 109
TABLE 39 OPTICAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION) 109
10 OPTICAL IMAGING MARKET, BY END USER 110
10.1 INTRODUCTION 111
TABLE 40 OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 111
10.2 HOSPITALS & CLINICS 111
10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET 111
TABLE 41 OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 112
10.3 RESEARCH LABORATORIES 113
10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH 113
TABLE 42 OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 114
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 114
10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET 114
TABLE 43 OPTICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 116
11 OPTICAL IMAGING MARKET, BY REGION 117
11.1 INTRODUCTION 118
FIGURE 29 OPTICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118
TABLE 44 OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119

11.2 NORTH AMERICA 119
11.2.1 NORTH AMERICA: RECESSION IMPACT 120
FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT 120
TABLE 45 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 46 NORTH AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121
TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 48 NORTH AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 49 NORTH AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 122
TABLE 50 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 51 NORTH AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 123
11.2.2 US 123
11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country 123
TABLE 52 US: MACROECONOMIC INDICATORS 124
TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124
TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 55 US: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 56 US: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 125
TABLE 57 US: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 58 US: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 126
11.2.3 CANADA 126
11.2.3.1 Availability of research funding to drive growth 126
TABLE 59 CANADA: MACROECONOMIC INDICATORS 126
TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 62 CANADA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 127
TABLE 63 CANADA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 128
TABLE 64 CANADA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 65 CANADA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 128

11.3 EUROPE 129
11.3.1 EUROPE: RECESSION IMPACT 129
FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT 130
TABLE 66 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 67 EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 69 EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 70 EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 132
TABLE 71 EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 72 EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 133
11.3.2 GERMANY 133
11.3.2.1 Robust healthcare spending to support market in Germany 133
TABLE 73 GERMANY: MACROECONOMIC INDICATORS 134
TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 76 GERMANY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 135
TABLE 77 GERMANY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 135
TABLE 78 GERMANY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 79 GERMANY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 136
11.3.3 FRANCE 136
11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth 136
TABLE 80 FRANCE: MACROECONOMIC INDICATORS 137
TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137
TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 83 FRANCE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 138
TABLE 84 FRANCE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 138
TABLE 85 FRANCE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138
TABLE 86 FRANCE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 139
11.3.4 UK 139
11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth 139
TABLE 87 UK: MACROECONOMIC INDICATORS 140
TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140
TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 90 UK: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 141
TABLE 91 UK: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 141
TABLE 92 UK: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 141
TABLE 93 UK: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 142
11.3.5 ITALY 142
11.3.5.1 Presence of major pharmaceutical & research institutes to drive market 142
TABLE 94 ITALY: MACROECONOMIC INDICATORS 143
TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 97 ITALY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 144
TABLE 98 ITALY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 144
TABLE 99 ITALY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
TABLE 100 ITALY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 145
11.3.6 SPAIN 145
11.3.6.1 Increasing development in biomedical sciences to drive growth 145
TABLE 101 SPAIN: MACROECONOMIC INDICATORS 146
TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146
TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 104 SPAIN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 147
TABLE 105 SPAIN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 147
TABLE 106 SPAIN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 107 SPAIN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 148
11.3.7 REST OF EUROPE 148
TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES 149
TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 111 REST OF EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 150
TABLE 112 REST OF EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 150
TABLE 113 REST OF EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 114 REST OF EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 151
11.4 ASIA PACIFIC 151
11.4.1 ASIA PACIFIC: RECESSION IMPACT 152
FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT 152
TABLE 115 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 116 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154
TABLE 119 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 154
TABLE 120 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 155
11.4.2 JAPAN 155
11.4.2.1 Established pharmaceutical & biotechnology research base to propel market 155
TABLE 122 JAPAN: MACROECONOMIC INDICATORS 156
TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156
TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 125 JAPAN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 157
TABLE 126 JAPAN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 157
TABLE 127 JAPAN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157
TABLE 128 JAPAN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 158
11.4.3 CHINA 158
11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth 158
TABLE 129 CHINA: MACROECONOMIC INDICATORS 159
TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 132 CHINA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 160
TABLE 133 CHINA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 160
TABLE 134 CHINA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 135 CHINA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 161
11.4.4 INDIA 161
11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market 161
TABLE 136 INDIA: MACROECONOMIC INDICATORS 162
TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 139 INDIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 163
TABLE 140 INDIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 163
TABLE 141 INDIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 142 INDIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 164
11.4.5 AUSTRALIA 164
11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market 164
TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS 164
TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 146 AUSTRALIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 165
TABLE 147 AUSTRALIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 166
TABLE 148 AUSTRALIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 149 AUSTRALIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 166
11.4.6 SOUTH KOREA 167
11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth 167
TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS 167
TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167
TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 153 SOUTH KOREA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 168
TABLE 154 SOUTH KOREA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 168
TABLE 155 OUTH KOREA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169
TABLE 156 SOUTH KOREA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 169
11.4.7 REST OF ASIA PACIFIC 169
TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 159 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 170
TABLE 160 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 171
TABLE 161 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171
TABLE 162 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 171
11.5 LATIN AMERICA 172
11.5.1 LATIN AMERICA: RECESSION IMPACT 172
TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 172
TABLE 164 LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 173
TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 166 LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 167 LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 174
TABLE 168 LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 174
TABLE 169 LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 174
11.5.2 BRAZIL 175
11.5.2.1 Improved GDP expenditure on healthcare 175
TABLE 170 BRAZIL: MACROECONOMIC INDICATORS 175
TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 173 BRAZIL: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 174 BRAZIL: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 176
TABLE 175 BRAZIL: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 176 BRAZIL: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 177
11.5.3 REST OF LATIN AMERICA 177
TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178
TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 179 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178
TABLE 180 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 179
TABLE 181 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179
TABLE 182 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 179
11.6 MIDDLE EAST & AFRICA 180
11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH 180
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 180
TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 181
TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 185 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 181
TABLE 186 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 182
TABLE 187 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 188 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 182
12 COMPETITIVE LANDSCAPE 183
12.1 INTRODUCTION 183
FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023) 184
12.2 REVENUE SHARE ANALYSIS 185
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET 185
12.3 MARKET SHARE ANALYSIS 186
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET, 2021 186
12.4 COMPANY EVALUATION QUADRANT 187
12.4.1 STARS 188
12.4.2 EMERGING LEADERS 188
12.4.3 PERVASIVE PLAYERS 188
12.4.4 PARTICIPANTS 188
FIGURE 36 OPTICAL IMAGING MARKET: GLOBAL COMPANY EVALUATION QUADRANT 189
12.5 START-UP/SME EVALUATION QUADRANT 190
12.5.1 PROGRESSIVE COMPANIES 190
12.5.2 STARTING BLOCKS 190
12.5.3 RESPONSIVE COMPANIES 190
12.5.4 DYNAMIC COMPANIES 190
FIGURE 37 OPTICAL IMAGING MARKET: GLOBAL START-UP/SME MATRIX 191
12.6 COMPETITIVE BENCHMARKING 192
12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS 192
12.6.2 PRODUCT FOOTPRINT 193
12.6.3 TECHNIQUE FOOTPRINT 194
12.6.4 THERAPEUTIC AREA FOOTPRINT 195
12.6.5 REGIONAL FOOTPRINT 196
12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS 197
FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS 197
12.8 COMPETITIVE SITUATION AND TRENDS 197
12.8.1 PRODUCT LAUNCHES & APPROVALS 198
TABLE 189 OPTICAL IMAGING MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023) 198
12.8.2 DEALS 198
TABLE 190 OPTICAL IMAGING MARKET: DEALS(JANUARY 2019 TO JANUARY 2023) 198
12.8.3 OTHER DEVELOPMENTS 199
TABLE 191 OPTICAL IMAGING MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023) 199
13 COMPANY PROFILES 200
13.1 KEY PLAYERS 200
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 CARL ZEISS MEDITEC AG 200
TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 200
FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021) 201
13.1.2 TOPCON CORPORATION 204
TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW 204
FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021) 205
13.1.3 CANON INC. 207
TABLE 194 CANON INC.: BUSINESS OVERVIEW 207
FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021) 208
13.1.4 ABBOTT LABORATORIES INC. 211
TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW 211
FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021) 212
13.1.5 KONINKLIJKE PHILIPS N.V. 215
TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 215
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 216
13.1.6 PERKINELMER, INC. 218
TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW 218
FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 219
13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION) 220
TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW 220
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 221
13.1.8 AGFA-GEVAERT N.V. 223
TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW 223
FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021) 224
13.1.9 HAMAMATSU PHOTONICS K.K. 225
TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW 225
FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021) 225
13.2 OTHER PLAYERS 227
13.2.1 HEIDELBERG ENGINEERING, INC. 227
TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW 227
13.2.2 HEADWALL PHOTONICS, INC. 229
TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW 229
13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.) 231
TABLE 203 VISIONIX: BUSINESS OVERVIEW 231
13.2.4 OPTICAL IMAGING LTD. 233
TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW 233
13.2.5 OPTOS 234
TABLE 205 OPTOS: BUSINESS OVERVIEW 234
13.2.6 WASATCH PHOTONICS 235
TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW 235
13.2.7 ARCSCAN INC. 236
TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW 236
13.2.8 DERMALUMICS 237
TABLE 208 DERMALUMICS: BUSINESS OVERVIEW 237
13.2.9 CYLITE PTY LTD. 238
TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW 238
13.2.10 MOPTIM 239
TABLE 210 MOPTIM: BUSINESS OVERVIEW 239
13.2.11 MICHELSON DIAGNOSTICS LTD. 240
TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW 240
13.2.12 THORLABS 241
TABLE 212 THORLABS: BUSINESS OVERVIEW 241
13.2.13 ITHERAMEDICAL 242
TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW 242
13.2.14 KIBERO 244
TABLE 214 KIBERO: BUSINESS OVERVIEW 244
13.2.15 SENO MEDICAL 246
TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW 246
13.2.16 ASPECTUS IMAGING 248
TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW 248
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 249
14.1 INSIGHTS FROM INDUSTRY EXPERTS 249
14.2 DISCUSSION GUIDE 250
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 255
14.4 CUSTOMIZATION OPTIONS 257
14.5 RELATED REPORTS 257
14.6 AUTHOR DETAILS 258



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 臨床試験用品の世界市場予測（～2028）：サービス別、フェーズ別、種類別、治療領域別、エンドユーザー別、地域別
  • 細胞分析の世界市場2023～2031：エンドユーザー別、治療領域別、技術別、作業場所別、国/地域別
  • 細胞分析用イメージベースサイトメトリーの世界市場2023～2031：エンドユーザー別、治療領域別、作業場所別、地域別
  • 医療機器設計・開発サービスの世界市場2023年～2030年：サービス別、医療機器別、治療領域別、エンドユーザー別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD2818-23 )"光学イメージングの世界市場予測（～2027）：製品別、技術別、治療領域別、用途別、エンドユーザー別" (英文：Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) - Global Forecast to 2027)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。